Loading clinical trials...
Loading clinical trials...
Phase I/II Study in Patients With Small Cell Lung Cancer (SCLC) of Veliparib in Combination With Topotecan
Conditions
Interventions
veliparib
Topotecan
Locations
1
Germany
Klinik München Gauting
München Gauting, Germany
Start Date
October 1, 2016
Primary Completion Date
May 1, 2021
Completion Date
June 1, 2021
Last Updated
January 27, 2021
Lead Sponsor
Central European Society for Anticancer Drug Research
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions